BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25205593)

  • 1. Amyloid-β efflux from the central nervous system into the plasma.
    Roberts KF; Elbert DL; Kasten TP; Patterson BW; Sigurdson WC; Connors RE; Ovod V; Munsell LY; Mawuenyega KG; Miller-Thomas MM; Moran CJ; Cross DT; Derdeyn CP; Bateman RJ
    Ann Neurol; 2014 Dec; 76(6):837-44. PubMed ID: 25205593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood.
    Monro OR; Mackic JB; Yamada S; Segal MB; Ghiso J; Maurer C; Calero M; Frangione B; Zlokovic BV
    Neurobiol Aging; 2002; 23(3):405-12. PubMed ID: 11959403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier.
    Erickson MA; Hartvigson PE; Morofuji Y; Owen JB; Butterfield DA; Banks WA
    J Neuroinflammation; 2012 Jun; 9():150. PubMed ID: 22747709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.
    Bateman RJ; Siemers ER; Mawuenyega KG; Wen G; Browning KR; Sigurdson WC; Yarasheski KE; Friedrich SW; Demattos RB; May PC; Paul SM; Holtzman DM
    Ann Neurol; 2009 Jul; 66(1):48-54. PubMed ID: 19360898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.
    Roher AE; Esh CL; Kokjohn TA; Castaño EM; Van Vickle GD; Kalback WM; Patton RL; Luehrs DC; Daugs ID; Kuo YM; Emmerling MR; Soares H; Quinn JF; Kaye J; Connor DJ; Silverberg NB; Adler CH; Seward JD; Beach TG; Sabbagh MN
    Alzheimers Dement; 2009 Jan; 5(1):18-29. PubMed ID: 19118806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier.
    Deane R; Wu Z; Zlokovic BV
    Stroke; 2004 Nov; 35(11 Suppl 1):2628-31. PubMed ID: 15459432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.
    Kasai T; Kondo M; Ishii R; Tanaka A; Ataka S; Shimada H; Tomiyama T; Mori H; Taylor M; Allsop D; Nakagawa M; Mizuno T; Tokuda T
    PLoS One; 2017; 12(4):e0174630. PubMed ID: 28394917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental investigation of antibody-mediated clearance mechanisms of amyloid-beta in CNS of Tg-SwDI transgenic mice.
    Vasilevko V; Xu F; Previti ML; Van Nostrand WE; Cribbs DH
    J Neurosci; 2007 Dec; 27(49):13376-83. PubMed ID: 18057195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease.
    Pyun JM; Kang MJ; Ryoo N; Suh J; Youn YC; Park YH; Kim S
    J Alzheimers Dis; 2020; 75(3):685-696. PubMed ID: 32390633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.
    Mohamed LA; Zhu H; Mousa YM; Wang E; Qiu WQ; Kaddoumi A
    J Alzheimers Dis; 2017; 56(3):1087-1099. PubMed ID: 28059785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis.
    Paganetti P; Antoniello K; Devraj K; Toni N; Kieran D; Madani R; Pihlgren M; Adolfsson O; Froestl W; Schrattenholz A; Liebner S; Havas D; Windisch M; Cirrito JR; Pfeifer A; Muhs A
    J Alzheimers Dis; 2014; 38(4):767-86. PubMed ID: 24072071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus.
    P X; Zz L; Gg J; Lp W; Cm B; Yl W; Chen MF; W L
    Neurochem Int; 2022 Nov; 160():105417. PubMed ID: 36067928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain insulin impairs amyloid-beta(1-40) clearance from the brain.
    Shiiki T; Ohtsuki S; Kurihara A; Naganuma H; Nishimura K; Tachikawa M; Hosoya K; Terasaki T
    J Neurosci; 2004 Oct; 24(43):9632-7. PubMed ID: 15509750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives.
    Cheng Y; Tian DY; Wang YJ
    Transl Neurodegener; 2020 May; 9(1):16. PubMed ID: 32381118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
    Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
    Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic Effects of Ethanol Exposure on Waste Metabolites Clearance in the CNS.
    Cheng Y; Ma X; Belfield KD; Haorah J
    Mol Neurobiol; 2021 Aug; 58(8):3953-3967. PubMed ID: 33895940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.